How Are Cancer Researchers Fighting COVID-19? (Part II)

Join us for part two of our virtual showcase of Koch Institute cancer researchers who have pivoted existing research to address biomedical challenges related to the COVID-19 pandemic. Four MIT faculty members will share their work developing new treatment strategies and interventions for the disease. After each presentation, a brief moderated Q&A session will allow participants to learn more about the science and understand how the Koch Institute’s flexible, collaborative research models accelerate innovation in the face of rapidly evolving understanding.

Featured presenters

Michael Yaffe, MD, PhD

David H. Koch Professor of Science; Intensive Care Physician, Beth Israel Deaconess Medical Center
Overcoming respiratory distress

Angela Koehler, PhD

Samuel A. Goldblith Career Development Professor in Applied Biology
Novel therapeutic candidates

Sangeeta Bhatia, MD, PhD

John J. and Dorothy Wilson Professor of Health Sciences and Technology and of Electrical Engineering and Computer Science
Nanomedicine for monitoring, prevention and therapy

Robert Langer, ScD

David H. Koch Institute Professor
Drug and vaccine delivery

Moderated by Salil Garg, MD, PhD

Charles W. (1955) and Jennifer C. Johnson Clinical Investigator

Watch Part I in this series: